Clinical Trial Update: Study of Docetaxel in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Sanofi-sponsored Phase 3 study of docetaxel in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED